This program is a satellite symposium prior to the American Society of Hematology (ASH) annual conference. This is the second time Mayo Medical Laboratories (MML) has conducted a satellite conference in conjunction with ASH. The symposium has been scheduled for Friday, Dec. 5 from 7-11 a.m.
This brand new course focuses on an update in infectious diseases subspecialties. It provides a comprehensive review of infectious diseases that focuses on the clinical application of new developments. The course offers case-based presentations, in-depth discussions and interactive sessions, all geared to increase knowledge, performance and patient outcomes. Attendees will leave with up-to-date, practical information that can be applied immediately to their clinical practice.
This program’s overall objective is to educate hematologists, oncologists and hematopathologists about cost-effective, diagnostically efficient test ordering strategies for evaluation of: erythrocytosis, complex hemoglobinopathies, disorders of hemostasis, myelodysplastic syndrome, chronic myeloproliferative neoplasms, acute myeloid leukemia, chronic lymphocytic leukemia, and
malignant lymphoma staging bone marrow.
Using test ordering algorithms based on data derived from the Mayo Clinic Hematology practice and literature, this symposium will illustrate how costly unnecessary biochemical, phenotypic and genetic testing can be eliminated from practices while maintaining highest quality medical care.
This three-day multidisciplinary conference explores current state-of-the art techniques and program development to implement a blood management program in hospitals. This is a one-of-a-kind summit organized by leaders in blood management from Mayo Clinic, Hartford Hospital, Loyola University, and Cleveland Clinic, with faculty participation from all four organizations.
The 20th International Surgical Pathology Symposium addresses the unique challenges and problems encountered in today’s surgical pathology practice. The course simulates the daily activities of the practicing surgical pathologist. The conference offers the opportunity to review case histories, view slides by virtual microscopy and formulate a diagnosis. The unique subtleties and differentiating characteristics of each diagnosis are then highlighted. Faculty and participants also discuss the patient management strategy used in each case. The symposium format features three or four specialty areas each day. Throughout the four-day conference, 38 cases are presented and discussed. Faculty from Mayo Clinic’s Department of Laboratory Medicine and Pathology present cases in following specialty areas: breast, endocrine, genito-urinary, gynecologic, head and neck, pulmonary, and soft tissue pathology.
2014 Angiogenesis and Tumor Microenvironment. This has been a very well-received, bi-annual event since 2006 targeting basic research scientists and clinical physicians with backgrounds in cardiovascular biology and developmental biology, myeloma, cancer, angiogenesis and related clinical trials, lymph angiogenesis, extracellular matrix, and anti-angiogenic therapy in differential tumors.
An estimated 37 million patients are affected by thrombotic disorders each year. This number will continue to rise with the increase in our aging population. This conference focuses on clinically applicable and cutting-edge methods used in the evaluation and treatment of patients with arterial and venous thrombotic disorders.
New this year, we have expanded our course to include an overview of vascular medicine content. This additional material will provide elements useful for providers caring for patients with a broad range of vascular diseases. The format of this content will also assist physicians preparing for the American Board of Vascular Medicine (ABVM) certification/recertification examinations. Lectures and case studies will be presented by Mayo Clinic faculty with ample opportunity to ask questions and discuss difficult diagnostic or management issues. Study questions will be covered during the conference.
This conference will focus on the reasons and practical how-to approaches that will better enable hospital laboratories and pathology practices to move toward value based medicine. Health care requires collaboration between patients, the hospital, physicians, pathologists and payers. New measurements are taking hold to include shared risk payment, quality impacts to reimbursement and realigned incentives. Test utilization management is an integral part of improving quality and outcomes at a lower cost.
This course will offer a range of perspectives from health care leaders including: payers, pathologists, genetic counselors and physicians from both large and small institutions. Based upon last year’s attendees, we expect to see a number of pathologist, physicians and healthcare executives in the audience, creating a forum for rich discussion and practice sharing. We hope to see you and your colleagues in Rochester this September.